fbpx
Septodont News2022-08-16T04:31:44-04:00

Septodont News

Septodont News

Septodont News

Biodentine XP awarded Product of the Year 2024

December 13th, 2023|

We are proud to announce that Biodentine XP has been nominated as the Product of the Year 2024 at the most significant dental congress in France and a leading dental scientific event in Europe - ADF Congress.

Septodont publishes its first Engagement Report

November 1st, 2023|

We are pleased to announce the publication of Septodont’s first Engagement Report, which reflects our long-standing commitments to corporate social responsibility and engagement toward building a sustainable future. This report showcases our achievements, challenges, and progress in making a positive impact for our clients, our patients, our partners and our employees.

Moderna and Septodont’s pharma division announce long-term agreement

May 4th, 2023|

Moderna, the biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Septodont’s pharma division, Novocol Pharma, announced a long-term agreement to perform aseptic fill-finish, labelling and packaging of mRNA respiratory vaccines.

Septodont announces collaboration with Immersify Education

March 8th, 2023|

Septodont, the world leader in dental pain management and proprietary of the Active Biosilicate Technology with Biodentine and BioRoot, is happy to announce its collaboration with Immersify Education.

Septodont Wins BFM Business Grand Prize for Mid-Sized Companies

September 29th, 2022|

The French business news channel, BFM Business, hosted on September 26th its annual Grand Prize award ceremony for mid-sized companies (“Les Grands Prix BFM Business des ETI”) and we are delighted to announce that Septodont has won the Grand Prize in the International category.

Septodont Acquires Biomedical Tissues

September 20th, 2022|

We are delighted to announce that Septodont has completed the acquisition of Biomedical Tissues (BMT), a French MedTech company at the forefront of tissue engineering. The company designs, produces and commercializes implantable membranes for tissue regeneration.

A proud moment for Septodont

September 14th, 2022|

Olivier Schiller, CEO of the Septodont Group, has won the EY Entrepreneur of the Year award 2022 for Ile-de-France in the Family Business category.

French Minister of Labor visits Septodont

September 13th, 2022|

Labor, Employment and Economic Inclusion Minister Olivier Dussopt accompanied by high officials from his ministry and local authorities visited Septodont on Monday 12th September.

Change Language
Local Websites
You are on the Septodont Corporate website. Choose your location to access your dedicated local website.